TY - JOUR T1 - Clinical and Epidemiological Correlates of Low IFN-Gamma Responses in Mitogen Tube of QuantiFERON Assay in Tuberculosis Infection Screening During the COVID-19 Pandemic: A Population-Based Marker of COVID-19 Mortality? JO - Archivos de Bronconeumología T2 - AU - Palacios-Gutiérrez,Juan-José AU - Rodríguez-Guardado,Azucena AU - Arias-Guillén,Miguel AU - Alonso-Arias,Rebeca AU - Palacios-Penedo,Sergio AU - García-García,José-María AU - Balbín,Milagros AU - Pérez-Hernández,Dolores AU - Sandoval-Torrientes,Marta AU - Torreblanca-Gil,Aurora AU - Melón,Santiago AU - Asensi-Álvarez,Víctor AU - Clain,Jeremy M. AU - Escalante,Patricio SN - 03002896 M3 - 10.1016/j.arbres.2022.01.011 DO - 10.1016/j.arbres.2022.01.011 UR - https://archbronconeumol.org/en-clinical-epidemiological-correlates-low-ifn-gamma-articulo-S0300289622000825 AB - BackgroundThe clinical and epidemiological implications of abnormal immune responses in COVID-19 for latent tuberculosis infection (LTBI) screening are unclear. MethodsWe reviewed QuantiFERON TB Gold Plus (QFT-Plus) results (36,709 patients) from July 2016 until October 2021 in Asturias (Spain). We also studied a cohort of ninety hospitalized patients with suspected/confirmed COVID-19 pneumonia and a group of elderly hospitalized patients with COVID-19 who underwent serial QFT-Plus and immune profiling testing. ResultsThe indeterminate QFT-Plus results rate went from 1.4% (July 2016 to November 2019) to 4.2% during the COVID-19 pandemic. The evolution of the number of cases with low/very low interferon-gamma (IFN-gamma) response in the mitogen tube paralleled the disease activity and number of deaths during the pandemic waves in our region (from March 2020 to October 2021). The percentages of positive QFT-plus patients did not significantly change before and during the pandemic (13.9% vs. 12.2%). Forty-nine patients from the suspected/confirmed COVID-19 pneumonia cohort (54.4%) had low/very low IFN-gamma response to mitogen, 22 of them (24.4%) had severe and critical pneumonia. None received immunosuppressants prior to testing. Abnormal radiological findings (P=0.01) but not COVID-19 severity was associated with low mitogen response. Immune profiling showed a reduction of CD8+T cells and a direct correlation between the number of EMRA CD8+T-cells and IFN-gamma response to mitogen (P=0.03). ConclusionLow IFN-gamma responses in mitogen tube of QFT-Plus often occur in COVID-19 pneumonia, which is associated with a low number of an effector CD8+T-cell subset and does not seem to affect LTBI screening; however, this abnormality seems to parallel the dynamics of COVID-19 at the population level and its mortality. ER -